Skip to Content

Newsroom

First-year progress in MD Anderson’s Moon Shots Program

10/18/2013

The University of Texas MD Anderson Cancer Center in September 2012 announced its Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program initially targets acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung cancer; melanoma; prostate cancer; and triple-negative breast and high-grade serious ovarian cancers. Elizabeth Grimm, Ph.D., interim director and chief scientific officer for MD Anderson’s Moon Shots Program, discusses progress since the effort launched one year ago.

Guest: Elizabeth Grimm, Ph.D.

Request an Appointment

Subscribe to Cancer Newsline


Subscribe to Cancer 
Newsline on iTunesU

What is iTunesU?iTunesU is a part of the iTunes Store that features free podcasts, lectures and other educational content that you can download to your Mac or PC, iPhone, iPod, or other portable device. 

Sign up to receive Cancer Newsline in your RSS Feed.

 



© 2014 The University of Texas MD Anderson Cancer Center